A Patient with Severe Leptospirosis Treated with Cytokine Removal and High-Dose Corticosteroids
Leptospirosis is an ubiquitous zoonosis with significant morbidity and mortality. Approximately 10 percent of human infections evolve into a severe form, with a sepsis-like disease, multiorgan failure, and significant mortality rate. The cornerstone of treatment of severe disease is antibiotic thera...
Saved in:
Main Authors: | Jure Fluher (Author), Iva Cestar (Author), Katja Jerenec (Author), Žiga Kalamar (Author), Zvonko Baklan (Author), Andrej Markota (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis.
by: Eliana A G Reis, et al.
Published: (2013) -
Can cytokines response play a role in the treatment of fatal leptospirosis?
by: Ahmad Alikhani, et al.
Published: (2022) -
Differential cytokine gene expression according to outcome in a hamster model of leptospirosis.
by: Frédérique Vernel-Pauillac, et al.
Published: (2010) -
Two cases of bullous systemic lupus erythematosus treated successfully with T2 and low-dose corticosteroids
by: Guangping Wang, et al.
Published: (2016) -
Magnetic Resonance Imaging Evaluation in Patients with Linear Morphea Treated with Methotrexate and High-Dose Corticosteroid
by: Mohammad Shahidi-Dadras, et al.
Published: (2018)